Denmark vs Sweden: The number of people with susceptibility test result for rifampicin
Denmark
96.58
in 2021
Sweden
96.65
in 2021
Denmark rank
43rd
Sweden rank
42nd
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Sweden
How they compare
Sweden currently reports 96.65 against 96.58 in Denmark, a difference of 0.07.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Denmark ahead.
Denmark ranks 43rd and Sweden ranks 42nd of 146 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.19 | 97.51 | 0.3152 | Sweden |
| 2020s | 96.41 | 96.61 | 0.1988 | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Sweden?
- Sweden, at 96.65 against 96.58 in Denmark as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Sweden?
- 0.07, with Sweden ahead.
- How many years of comparable data are there for Denmark and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 43rd and Sweden ranks 42nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.